z-logo
Premium
Partial deletion of the MAPT gene: A novel mechanism of FTDP‐17
Author(s) -
RoveletLecrux Anne,
Lecourtois Magalie,
ThomasAnterion Catherine,
Le Ber Isabelle,
Brice Alexis,
Frebourg Thierry,
Hannequin Didier,
Campion Dominique
Publication year - 2009
Publication title -
human mutation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.981
H-Index - 162
eISSN - 1098-1004
pISSN - 1059-7794
DOI - 10.1002/humu.20979
Subject(s) - biology , microtubule , tauopathy , exon , frontotemporal dementia , tau protein , gene , gene isoform , microtubule associated protein , mechanism (biology) , genetics , binding domain , function (biology) , alternative splicing , microbiology and biotechnology , binding site , alzheimer's disease , dementia , neurodegeneration , disease , medicine , philosophy , epistemology , pathology
A heterozygous genomic deletion removing exons 6 to 9 of the microtubule associated protein tau (MAPT) gene, predicting to result into a truncated protein lacking the first microtubule binding domain, was detected in a patient with frontotemporal dementia (FTD). Cell culture experiments showed that the truncated tau isoforms had a dramatic decrease in the normal binding to microtubules but acquired the ability to bind microtubule associated protein‐1B (MAP‐1B). This indicates that this tauopathy likely results both from a loss of function mechanism and from a deleterious gain of function by which cytoplasmic deleted forms of tau sequester another MAP. Both mechanisms could contribute to impair microtubule dynamics. © 2009 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom